316 related articles for article (PubMed ID: 16807982)
21. Matrix metalloproteinase localisation by in situ-RT-PCR in archival human breast biopsy material.
Haupt LM; Irving RE; Weinstein SR; Irving MG; Griffiths LR
Mol Cell Probes; 2008 Apr; 22(2):83-9. PubMed ID: 17669621
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis.
Määttä M; Soini Y; Liakka A; Autio-Harmainen H
Clin Cancer Res; 2000 Jul; 6(7):2726-34. PubMed ID: 10914717
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical study of matrix metalloproteinase 9 and tissue inhibitor of matrix metalloproteinase 1 in benign and malignant breast tissue--strong expression in intraductal carcinomas of the breast.
Rahko E; Kauppila S; Pääkkö P; Blanco G; Apaja-Sarkkinen M; Talvensaari-Mattila A; Turpeenniemi-Hujanen T; Jukkola A
Tumour Biol; 2009; 30(5-6):257-64. PubMed ID: 19887890
[TBL] [Abstract][Full Text] [Related]
24. Expression of MMP and TIMP mRNA in peripheral blood leukocytes of patients with invasive ductal carcinoma of the breast.
Wieczorek E; Galicki M; Tomasik B; Krol M; Jablonska E; Fendler W; Gromadzinska J; Morawiec Z; Wasowicz W; Reszka E
Int J Biol Markers; 2016 Jul; 31(3):e309-16. PubMed ID: 27032379
[TBL] [Abstract][Full Text] [Related]
25. Elevated ratio of MMP2/MMP9 activity is associated with poor response to chemotherapy in osteosarcoma.
Kunz P; Sähr H; Lehner B; Fischer C; Seebach E; Fellenberg J
BMC Cancer; 2016 Mar; 16():223. PubMed ID: 26979530
[TBL] [Abstract][Full Text] [Related]
26. Matrix metalloproteinase expression and function during fin regeneration in zebrafish: analysis of MT1-MMP, MMP2 and TIMP2.
Bai S; Thummel R; Godwin AR; Nagase H; Itoh Y; Li L; Evans R; McDermott J; Seiki M; Sarras MP
Matrix Biol; 2005 Jun; 24(4):247-60. PubMed ID: 15935631
[TBL] [Abstract][Full Text] [Related]
27. Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions.
Davidson B; Goldberg I; Berner A; Nesland JM; Givant-Horwitz V; Bryne M; Risberg B; Kristensen GB; Tropé CG; Kopolovic J; Reich R
Am J Clin Pathol; 2001 Apr; 115(4):517-24. PubMed ID: 11293899
[TBL] [Abstract][Full Text] [Related]
28. Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas.
Jones JL; Glynn P; Walker RA
J Pathol; 1999 Oct; 189(2):161-8. PubMed ID: 10547569
[TBL] [Abstract][Full Text] [Related]
29. Expression and localization of matrix metalloproteinases (MT1-MMP, MMP-2) and tissue inhibitor of metalloproteinase-2 (TIMP-2) during synepitheliochorial placentation of goats (Capra hircus).
Uekita T; Yamanouchi K; Sato H; Tojo H; Seiki M; Tachi C
Placenta; 2004 Nov; 25(10):810-9. PubMed ID: 15451196
[TBL] [Abstract][Full Text] [Related]
30. Platelet release of trimolecular complex components MT1-MMP/TIMP2/MMP2: involvement in MMP2 activation and platelet aggregation.
Kazes I; Elalamy I; Sraer JD; Hatmi M; Nguyen G
Blood; 2000 Nov; 96(9):3064-9. PubMed ID: 11049985
[TBL] [Abstract][Full Text] [Related]
31. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human urothelial carcinomas.
Kitagawa Y; Kunimi K; Ito H; Sato H; Uchibayashi T; Okada Y; Seiki M; Namiki M
J Urol; 1998 Oct; 160(4):1540-5. PubMed ID: 9751409
[TBL] [Abstract][Full Text] [Related]
32. The clinicopathological and prognostic significance of membrane type 1 matrix metalloproteinase (MT1-MMP) and MMP-9 according to their localization in invasive breast carcinoma.
Mylona E; Nomikos A; Magkou C; Kamberou M; Papassideri I; Keramopoulos A; Nakopoulou L
Histopathology; 2007 Feb; 50(3):338-47. PubMed ID: 17257129
[TBL] [Abstract][Full Text] [Related]
33. Alterations in enhancer of zeste homolog 2, matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression are associated with ex vivo and in vitro bone metastasis in renal cell carcinoma.
Wang J; Ren Y; Guo X; Cheng H; Ye Y; Qi J; Yang C; You H
Mol Med Rep; 2015 May; 11(5):3585-92. PubMed ID: 25571919
[TBL] [Abstract][Full Text] [Related]
34. [Association of JMJD3, MMP-2 and VEGF expressions with clinicopathological features of invasive ductal breast carcinoma].
Xu X; Wang J; Yan C; Men Y; Jiang H; Fang H; Xu X; Yang J
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Nov; 40(11):1593-1600. PubMed ID: 33243732
[TBL] [Abstract][Full Text] [Related]
35. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas.
Nakamura H; Ueno H; Yamashita K; Shimada T; Yamamoto E; Noguchi M; Fujimoto N; Sato H; Seiki M; Okada Y
Cancer Res; 1999 Jan; 59(2):467-73. PubMed ID: 9927064
[TBL] [Abstract][Full Text] [Related]
36. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H
Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
[TBL] [Abstract][Full Text] [Related]
37. Matrix metalloproteinase expression patterns in luminal A type breast carcinomas.
Decock J; Hendrickx W; Drijkoningen M; Wildiers H; Neven P; Smeets A; Paridaens R
Dis Markers; 2007; 23(3):189-96. PubMed ID: 17473389
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation.
Muñoz-Nájar UM; Neurath KM; Vumbaca F; Claffey KP
Oncogene; 2006 Apr; 25(16):2379-92. PubMed ID: 16369494
[TBL] [Abstract][Full Text] [Related]
39. Metalloproteinase and tissue inhibitor of metalloproteinase expression in the murine STR/ort model of osteoarthritis.
Flannelly J; Chambers MG; Dudhia J; Hembry RM; Murphy G; Mason RM; Bayliss MT
Osteoarthritis Cartilage; 2002 Sep; 10(9):722-33. PubMed ID: 12202125
[TBL] [Abstract][Full Text] [Related]
40. Quantitative immunohistochemical and in situ hybridization analysis of metalloproteinases in prostate cancer.
Cardillo MR; Di Silverio F; Gentile V
Anticancer Res; 2006; 26(2A):973-82. PubMed ID: 16619495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
